AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including new initiatives to support veterans' mental health, a livestream for Alzheimer's Awareness Month and a ...